Natera (NTRA) Competitors

$106.46
-2.04 (-1.88%)
(As of 05/17/2024 ET)

NTRA vs. EXAS, DGX, LH, RDNT, FTRE, FMS, UTHR, RDY, UHS, and DVA

Should you be buying Natera stock or one of its competitors? The main competitors of Natera include Exact Sciences (EXAS), Quest Diagnostics (DGX), Laboratory Co. of America (LH), RadNet (RDNT), Fortrea (FTRE), Fresenius Medical Care (FMS), United Therapeutics (UTHR), Dr. Reddy's Laboratories (RDY), Universal Health Services (UHS), and DaVita (DVA). These companies are all part of the "medical" sector.

Natera vs.

Exact Sciences (NASDAQ:EXAS) and Natera (NASDAQ:NTRA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment, community ranking and profitability.

Exact Sciences has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500.

88.8% of Exact Sciences shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 1.3% of Exact Sciences shares are owned by insiders. Comparatively, 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Exact Sciences has higher revenue and earnings than Natera. Exact Sciences is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exact Sciences$2.50B3.72-$204.15M-$1.32-38.17
Natera$1.08B12.08-$434.80M-$3.12-34.12

Exact Sciences received 493 more outperform votes than Natera when rated by MarketBeat users. Likewise, 72.46% of users gave Exact Sciences an outperform vote while only 68.52% of users gave Natera an outperform vote.

CompanyUnderperformOutperform
Exact SciencesOutperform Votes
950
72.46%
Underperform Votes
361
27.54%
NateraOutperform Votes
457
68.52%
Underperform Votes
210
31.48%

Exact Sciences presently has a consensus target price of $95.40, suggesting a potential upside of 89.36%. Natera has a consensus target price of $98.47, suggesting a potential downside of 7.51%. Given Natera's higher probable upside, equities analysts clearly believe Exact Sciences is more favorable than Natera.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exact Sciences
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92
Natera
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Natera had 9 more articles in the media than Exact Sciences. MarketBeat recorded 27 mentions for Natera and 18 mentions for Exact Sciences. Exact Sciences' average media sentiment score of 0.66 beat Natera's score of 0.36 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exact Sciences
6 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Natera
7 Very Positive mention(s)
6 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Exact Sciences has a net margin of -9.48% compared to Exact Sciences' net margin of -30.24%. Natera's return on equity of -7.12% beat Exact Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Exact Sciences-9.48% -7.12% -3.46%
Natera -30.24%-49.72%-26.08%

Summary

Exact Sciences and Natera tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NTRA vs. The Competition

MetricNateraMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$13.07B$2.34B$5.08B$7.95B
Dividend YieldN/A1.82%36.93%3.91%
P/E Ratio-34.1215.47149.4316.85
Price / Sales12.08128.802,348.8776.74
Price / CashN/A384.4736.1232.08
Price / Book16.453.855.714.68
Net Income-$434.80M-$135.88M$104.82M$216.90M
7 Day Performance1.11%1.04%1.92%2.94%
1 Month Performance17.86%7.33%4.23%6.23%
1 Year Performance114.46%-6.48%6.42%9.80%

Natera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXAS
Exact Sciences
4.6823 of 5 stars
$61.41
-3.1%
$99.07
+61.3%
-35.9%$11.29B$2.50B-53.876,600Short Interest ↓
DGX
Quest Diagnostics
4.9454 of 5 stars
$136.96
+1.0%
$146.17
+6.7%
+9.2%$15.21B$9.25B18.4348,000Dividend Announcement
Short Interest ↓
Analyst Revision
LH
Laboratory Co. of America
4.9837 of 5 stars
$201.50
+0.2%
$243.14
+20.7%
-3.0%$16.99B$12.16B40.5467,000Insider Selling
Short Interest ↓
RDNT
RadNet
3.3102 of 5 stars
$52.47
+0.9%
$53.67
+2.3%
+106.4%$3.88B$1.62B-2,622.1910,288Analyst Forecast
FTRE
Fortrea
2.9958 of 5 stars
$36.47
+0.4%
$37.29
+2.2%
N/A$3.26B$3.11B0.0018,000Earnings Report
Analyst Upgrade
News Coverage
FMS
Fresenius Medical Care
2.4511 of 5 stars
$20.12
-6.1%
$24.00
+19.3%
-5.2%$11.81B$21.05B21.871,358Analyst Forecast
Positive News
Gap Down
UTHR
United Therapeutics
4.8947 of 5 stars
$266.22
+2.2%
$308.78
+16.0%
+26.9%$11.81B$2.33B12.591,168Analyst Upgrade
Insider Selling
RDY
Dr. Reddy's Laboratories
0.6919 of 5 stars
$71.44
-4.6%
$80.00
+12.0%
+25.0%$11.92B$2.99B18.8525,863Analyst Downgrade
UHS
Universal Health Services
4.9046 of 5 stars
$169.50
+0.2%
$183.20
+8.1%
+32.2%$11.39B$14.28B14.3696,700Dividend Announcement
DVA
DaVita
3.7696 of 5 stars
$137.79
+0.7%
$121.33
-11.9%
+41.8%$12.08B$12.14B15.6670,000Analyst Forecast
Insider Selling

Related Companies and Tools

This page (NASDAQ:NTRA) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners